IRIS Accounts Production v25.3.0.601 08966010 director 1.4.24 31.3.25 31.3.25 No description of principal activity 0 0 false true false false true true Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh089660102024-03-31089660102025-03-31089660102024-04-012025-03-31089660102023-03-31089660102023-04-012024-03-31089660102024-03-3108966010ns15:EnglandWales2024-04-012025-03-3108966010ns14:PoundSterling2024-04-012025-03-3108966010ns10:Director12024-04-012025-03-3108966010ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3108966010ns10:SmallEntities2024-04-012025-03-3108966010ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3108966010ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3108966010ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3108966010ns10:FullAccounts2024-04-012025-03-3108966010ns10:EntityNoLongerTradingButTradedInPast2024-04-012025-03-3108966010ns10:OrdinaryShareClass12024-04-012025-03-3108966010ns10:RegisteredOffice2024-04-012025-03-3108966010ns5:ShareCapital2025-03-3108966010ns5:ShareCapital2024-03-3108966010ns5:RetainedEarningsAccumulatedLosses2025-03-3108966010ns5:RetainedEarningsAccumulatedLosses2024-03-3108966010ns5:CurrentFinancialInstruments2025-03-3108966010ns5:CurrentFinancialInstruments2024-03-3108966010ns10:OrdinaryShareClass12025-03-31
REGISTERED NUMBER: 08966010 (England and Wales)






























UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

FOR

L.IN.C. MEDICAL LIMITED

L.IN.C. MEDICAL LIMITED (REGISTERED NUMBER: 08966010)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3

L.IN.C. MEDICAL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2025







DIRECTOR: Mr S W Bailey





REGISTERED OFFICE: 7 Kingsley Street
Leicester
Leicestershire
LE2 6DY





REGISTERED NUMBER: 08966010 (England and Wales)

L.IN.C. MEDICAL LIMITED (REGISTERED NUMBER: 08966010)

BALANCE SHEET
31 MARCH 2025

2025 2024
Notes £    £   
CURRENT ASSETS
Debtors 4 10,426 10,426
TOTAL ASSETS LESS CURRENT
LIABILITIES

10,426

10,426

CAPITAL AND RESERVES
Called up share capital 5 1 1
Retained earnings 10,425 10,425
SHAREHOLDERS' FUNDS 10,426 10,426

The company is entitled to exemption from audit under Section 480 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 8 October 2025 and were signed by:





Mr S W Bailey - Director


L.IN.C. MEDICAL LIMITED (REGISTERED NUMBER: 08966010)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025


1. STATUTORY INFORMATION

L.IN.C. Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Debtors
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Creditors
Short term trade creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2024 - NIL).

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Amounts owed by group undertakings 10,426 10,426

5. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
1 Ordinary £1 1 1